Poseida Therapeutics, Inc.

Q1 2023 13F Holders

Symbol
PSTX
CUSIP
73730P108
Type
Equity
Class
COM
Num filings
105
Total reported value, excl. options
$136 M
Manager Report Date Value ($000) Shares Option Type